Molecular mechanisms of increased intrahepatic resistance in portal hypertension
- PMID: 17975474
- DOI: 10.1097/MCG.0b013e318150d0e1
Molecular mechanisms of increased intrahepatic resistance in portal hypertension
Abstract
Portal hypertension is associated with changes in the intrahepatic, systemic, and portosystemic collateral circulation. Alterations in vasoreactivity (vasodilation and vasoconstriction) play a central role in the pathogenesis of portal hypertension by contributing to increased intrahepatic resistance, hyperdynamic circulation, and expansion of the collateral circulation. Portal hypertension is also importantly characterized by changes in vascular structure; termed vascular remodeling, which is an adaptive response of the vessel wall that occurs in response to chronic changes in the environment such as shear stress. These complementary processes of vasoreactivity and vascular remodeling contribute importantly to increased intrahepatic resistance and represent important targets in the treatment of portal hypertension. This review will focus on these processes within the intrahepatic circulation, a circulatory bed whose study, that Dr Roberto Groszmann has pioneered.
Similar articles
-
Vascular deterioration in cirrhosis: the big picture.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S247-53. doi: 10.1097/MCG.0b013e3181572357. J Clin Gastroenterol. 2007. PMID: 17975472 Review.
-
Pathophysiology of portal hypertension.J Physiol Pharmacol. 2008 Aug;59 Suppl 2:231-8. J Physiol Pharmacol. 2008. PMID: 18812641 Review.
-
Hemodynamics in the isolated cirrhotic liver.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S254-8. doi: 10.1097/MCG.0b013e318150d3b5. J Clin Gastroenterol. 2007. PMID: 17975473 Review.
-
[Pathophysiology of portal hypertension, what's new?].Korean J Gastroenterol. 2010 Sep;56(3):129-34. doi: 10.4166/kjg.2010.56.3.129. Korean J Gastroenterol. 2010. PMID: 20847603 Review. Korean.
-
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.Gastroenterology. 2007 Feb;132(2):709-19. doi: 10.1053/j.gastro.2006.12.041. Epub 2006 Dec 20. Gastroenterology. 2007. PMID: 17258737
Cited by
-
Angiocrine signaling in the hepatic sinusoids in health and disease.Am J Physiol Gastrointest Liver Physiol. 2016 Aug 1;311(2):G246-51. doi: 10.1152/ajpgi.00118.2016. Epub 2016 Jun 10. Am J Physiol Gastrointest Liver Physiol. 2016. PMID: 27288423 Free PMC article. Review.
-
Management of Preoperative Recipient Portal Vein Thrombosis in Living-donor Liver Transplantation.J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102445. doi: 10.1016/j.jceh.2024.102445. Epub 2024 Nov 13. J Clin Exp Hepatol. 2025. PMID: 39802411 Review.
-
Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges.World J Gastroenterol. 2024 Jan 28;30(4):290-307. doi: 10.3748/wjg.v30.i4.290. World J Gastroenterol. 2024. PMID: 38313235 Free PMC article. Review.
-
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation.World J Gastroenterol. 2009 May 7;15(17):2097-108. doi: 10.3748/wjg.15.2097. World J Gastroenterol. 2009. PMID: 19418582 Free PMC article.
-
Selective gene expression profiling contributes to a better understanding of the molecular pathways underlying the histological changes observed after RHMVL.BMC Med Genomics. 2022 Oct 7;15(1):211. doi: 10.1186/s12920-022-01364-z. BMC Med Genomics. 2022. PMID: 36207717 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources